AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$BFLY

Butterfly Network, Inc. Q3 2026 Earnings Call Summary

Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.

Original reporting
finance.yahoo.com
Published Oct 29, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 5:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Butterfly Network, Inc. Q3 2026 Earnings Call Summary — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$BFLYBullishMed
01

Why it matters

The earnings call highlighted record gross margins, guidance upgrades, and a new financing vehicle, all of which could influence the stock's short-term trajectory.

02

Market read

The company's earnings beat and financing news provide a fresh catalyst for traders, especially those tracking med‑tech and AI‑driven health tech stocks.

03

What to watch

The $150M shelf may indicate cash burn concerns; upcoming chip launches could delay profitability.

Relevance 7/10Novelty 7/10Timing: after-hours reaction

Background

Butterfly Network is a medical imaging company focusing on handheld ultrasound devices with AI integration.

Company-level read

Ticker impact

$BFLYBullishHigh confidence
Context

Butterfly Network disclosed Q3 2026 results, raised full-year guidance and announced a $150M shelf registration.

Expected impact

likely modest upside as market prices in higher revenue outlook and financing flexibility

Evidence & confidence

Earnings beat and guidance lift are fresh primary disclosures that can move the stock in the near term.

Market effects

Sector

Signals growing demand for enterprise ultrasound solutions, potentially benefiting peers in medical imaging.

Regional

U.S. healthcare providers may increase spend on embedded AI ultrasound platforms.

Global

International rollout remains lagging, but FedRAMP clearance could open federal contracts.

Counterpoint

What could challenge this read

Embedded revenue volatility may pressure margins; investors should watch for execution risk on international expansion.

Key entities

  • Company
    Butterfly Network, Inc.

    Provider of AI‑enabled handheld ultrasound devices.

Read at source← All news

Also covered by

1 outlet

Related articles

$BFLYHigh

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network (BFLY) reported Q3 record gross profit of $23.8M, up from a $3.8M loss last year. Adjusted EBITDA loss narrowed to $1.2M. Full-year 2026 revenue guidance raised to $123M-$126M. Company plans international strategy shift and expects FedRAMP authorization to boost government business. Cash reserves at $122M.

finance.yahoo.com
$BFLYMed

Butterfly (BFLY) Q3 2026 Earnings Call Transcript

Butterfly (BFLY) reported Q3 2026 revenue of $32.6M, beating guidance by 9%. The company raised full-year guidance and highlighted growth in U.S. enterprise contracts and international expansion. Key developments include FedRAMP authorization for federal government contracts and new partnerships in brain-computer interface and healthcare applications.

finance.yahoo.com
$BFLYMed

Butterfly Network Reports Third Quarter 2026 Financial Results

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million, driven in part by Embedded revenue • Recorded highest gross margin in Company history at 73

SEC EDGAR 8-K
$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

investorplace.com
$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

investing.com
$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

investing.com